|
PRPF40A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.823400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.002200E-02 |
| Normal-vs-Stage2 |
3.658400E-01 |
| Normal-vs-Stage3 |
1.124010E-03 |
| Normal-vs-Stage4 |
8.564000E-04 |
| Stage1-vs-Stage2 |
8.597200E-01 |
| Stage1-vs-Stage3 |
4.567700E-02 |
| Stage1-vs-Stage4 |
3.069600E-02 |
| Stage2-vs-Stage3 |
1.713440E-01 |
| Stage2-vs-Stage4 |
1.468980E-01 |
| Stage3-vs-Stage4 |
7.479000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.141300E-03 |
| Normal-vs-AfricanAmerican |
1.217770E-03 |
| Normal-vs-Asian |
9.974000E-01 |
| Caucasian-vs-AfricanAmerican |
1.734160E-01 |
| Caucasian-vs-Asian |
4.488600E-01 |
| AfricanAmerican-vs-Asian |
1.658180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.551100E-04 |
| Normal-vs-Female |
1.492990E-01 |
| Male-vs-Female |
3.463600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.443500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.046100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.683800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.934210E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.222200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.510400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.649400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.080800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.058200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.038200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.293000E-01 |
| Normal-vs-Grade 2 |
1.866970E-01 |
| Normal-vs-Grade 3 |
2.447500E-04 |
| Normal-vs-Grade 4 |
1.122840E-03 |
| Grade 1-vs-Grade 2 |
4.566600E-01 |
| Grade 1-vs-Grade 3 |
5.998400E-02 |
| Grade 1-vs-Grade 4 |
5.715900E-02 |
| Grade 2-vs-Grade 3 |
9.937100E-03 |
| Grade 2-vs-Grade 4 |
2.102300E-02 |
| Grade 3-vs-Grade 4 |
5.176600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.029800E-01 |
| Normal-vs-ccB subtype |
9.020700E-04 |
| ccA subtype-vs-ccB subtype |
1.276760E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.798460E-02 |
| Normal-vs-N1 |
4.026400E-01 |
| N0-vs-N1 |
9.434600E-01 |
|
|
